ICICI Prudential Nifty Pharma Index Fund
NAV
₹20.42
as of 21 Aug 2026
ICICI Prudential Nifty Pharma Index Fund is an open-ended Index Funds scheme from ICICI Prudential Mutual Fund managing ₹148 crore (as of 31 Jul 2026). Its Direct-plan NAV is ₹20.42 as of 21 Aug 2026. The expense ratio is 0.32% a year. Managed by Nishit Patel. This page is factual data only — it carries no rating and no recommendation.
Key facts
- Expense ratio
- 0.32% / yr
- as of 30 Jun 2026
- Fund size
- ₹148 crore
- as of 31 Jul 2026
- Exit load
- None
- SIP available
- Yes
- Launched
- 15 Dec 2022
- ISIN
- INF109KC11M9
₹100 invested, fund vs category
The category line is the average of the funds in this category, built from NYVO’s own NAV data.
Rebased to 100data to 20 Aug 2026Benchmark: Nifty Pharma
ICICI Prudential Nifty Pharma Index Fund
₹206
+106% on ₹100 over 3.7 yrs
Index Funds average
₹172
+72% on ₹100 over 3.7 yrs
Returns vs category
| Window | Fund | Category avg | Gap |
|---|---|---|---|
| 3 months | 7.74% | 6.36% | +1.38 |
| 6 months | 17.09% | 15.40% | +1.69 |
| 1 year | 20.29% | 15.64% | +4.65 |
| 3 years (CAGR) | 19.94% | 20.47% | -0.53 |
No category average is available for this fund. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.
A single return number depends on its start date. These are ALL the overlapping holding periods, so the worst case is visible — read that number first.
1-year holding periods
- Worst
- -6.5%
- Median
- 15.8%
- Best
- 58.8%
33 windows over the last 44 months, stepped monthly; 88% ended positive. Worst window began 1 Oct 2024. Windows overlap — this is the range of past start dates, not a probability of anything.
3-year holding periods (per year)
- Worst
- 20.2%
- Median
- 22.0%
- Best
- 24.7%
9 windows over the last 44 months, stepped monthly; 100% ended positive. Worst window began 1 Feb 2023. Windows overlap — this is the range of past start dates, not a probability of anything.
Risk, measured
- Sharpe ratio (3Y)
- 0.89
- Sortino ratio (3Y)
- 1.50
- Standard deviation (3Y)
- 15.97%
Distance below its own peak
Every dip below 0 is the fund trading under a previous high — how deep and for how long is what a drawdown feels like.
Deepest fall
-15.2%
Right now
-1.3% below peak
Where the money actually is
Equity
100.0%
Cash
0.0%
Whole-portfolio split, as of 31 Jul 2026. The size split below covers only the equity slice of this.
What it owns
22 positions · top 10 = 79.1%
Market-cap mix (equity sleeve)
Large 47.7%Mid 45.5%Small 6.7%Other 0.1%
as of 31 Jul 2026
Holdings by sector
Healthcare(10 in top 10)100.0%
- Sun Pharmaceuticals Industries Ltd21.33%
- Divi's Laboratories Ltd10.36%
- Cipla Ltd8.39%
- Torrent Pharmaceuticals Ltd7.60%
- Laurus Labs Ltd7.15%
- Dr Reddy's Laboratories Ltd7.08%
- Lupin Ltd5.94%
- Aurobindo Pharma Ltd4.43%
- Alkem Laboratories Ltd3.40%
- Glenmark Pharmaceuticals Ltd3.40%
Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Jul 2026. Portfolio turnover 86.0% vs category 35.3% a year.
Money in, money out
- Net flow, 12 months
- +₹34 cr
- Net flow, 3 months
- +₹18 cr
as of 31 Jul 2026. Flows follow performance more than they predict it.
Quick answers
- What is the NAV of ICICI Prudential Nifty Pharma Index Fund?
- ₹20.42 per unit as of 21 Aug 2026 (Direct plan, growth). NAV is declared daily on working days.
- What is the expense ratio of ICICI Prudential Nifty Pharma Index Fund?
- 0.32% a year for the Direct plan, as of 30 Jun 2026.
- How large is ICICI Prudential Nifty Pharma Index Fund?
- ₹148 crore under management as of 31 Jul 2026, in the Index Funds category.
- How risky is ICICI Prudential Nifty Pharma Index Fund?
- Its SEBI Riskometer reading is "Very High Risk". Own the whole market, pay almost nothing. A great deal of the ETF money is EPFO's.
- What is the worst 3-year return of ICICI Prudential Nifty Pharma Index Fund?
- 20.2% a year — the weakest of 9 overlapping 3-year holding periods, beginning 1 Feb 2023. The median was 22.0% and 100% of those windows ended positive. Windows overlap, so this is the range of past start dates, not a probability.
- Who manages ICICI Prudential Nifty Pharma Index Fund?
- Nishit Patel, managing this fund for 3.6 years.
Where this fund sits
Its shelf, all funds
Ix · Index funds & ETFs →
Own the whole market, pay almost nothing. A great deal of the ETF money is EPFO's.
The money map
How big this shelf is in India →
The whole industry sized by real money, from AMFI’s monthly data.
Side by side
Compare this fund →
Put it next to any other fund — growth, returns, risk and cost in one table.
One bet or two?
Check its overlap →
See whether it owns the same stocks as your other funds.
Other Index Funds funds
- UTI Nifty 50 Index Fund₹29,603 crore
- HDFC Nifty 50 Index Fund₹24,190 crore
- ICICI Prudential Nifty 50 Index Fund₹17,353 crore
- ICICI Prudential Nifty Next 50 Index Fund₹9,935 crore
- UTI Nifty50 Equal Weight Index Fund₹153 crore
- Aditya Birla Sun Life CRISIL IBX SDL Jun 2032 Index Fund₹150 crore
- Sundaram Nifty 100 Equal Weight Fund (Formerly Known as Principal Nifty 100 Equal Weight Fund₹147 crore
- HDFC NIFTY Realty Index Fund₹146 crore
Data: NYVO research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty Pharma) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.